MACROLONE GRANULES ANTI-INFLAMMATORY ANTI-ALLERGY
Страна: Австралія
мова: англійська
Джерело: APVMA (Australian Pesticides and Veterinary Medicines Authority)
інформаційний буклет
(PIL)
19-06-2017
Характеристики продукта
(SPC)
19-06-2017
Активний інгредієнт:
PREDNISOLONE
Доступна з:
MAVLAB PTY. LTD.
ІПН (Міжнародна Ім'я):
prednisolone(20mg/g)
Фармацевтична форма:
ORAL GRANULES, PELLETS
Склад:
PREDNISOLONE STEROID-GLUCOCORTICOID Active 20.0 mg/g
Одиниць в упаковці:
150g
Клас:
VM - Veterinary Medicine
Терапевтична група:
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
Терапевтична области:
ENDOCRINE SYSTEM
Терапевтичні свідчення:
CORTICOSTEROID | ADVANCING PARTURITION | ALLERGIC REACTIONS | ANTIADRENAL SUPPRESSION | ANTI-INFLAMMATORY | ANTISHOCK | ARTHRITIS | BRONCHITIS | CATABOLIC COMPLICATIONS | CHRONIC BRONCHITIS | CORTICOSTEROIDS | CORTICOSTEROIDS AND RELATE | COUGHS | DERMATITIS | DERMATOLOGICAL DISORDERS | DERMATOSES | ECZEMA | GLUCOGENIC STEROID | JOINT DISEASE | KETOSIS | LOCOMOTIVE DISEASES | MUSCULO SKELETAL INFLAMMAT | ORTHOPAEDIC | PARTURIENT UDDER OEDEMA | PARTURITION | PRURITIS | RESPIRATORY TRACT DISEASES | RHEUMATIC DISEASES | STRESS | TOXAEMIA | WATER RETENTION
Огляд продуктів:
Poison schedule: 4; Withholding period: WHP: DO NOT USE less than 28 days befor e slaughter for human consumption.; Host/pest details: HORSE: [CORTICOSTEROID]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [CORTICOSTEROID]; For the treatment of inflammatory and allergic conditions in horses.See product label for details.
Статус Авторизація:
Registered
Дата Авторизація:
2023-07-01
інформаційний буклет
I
Mavlab logo
We Do Care
33 Rowland St.,
Slacks Creek,
Qld 4127
For the treatment
of
inflammatory and allergic
conditions in horses.
ACTIVE CONSTITUENT:
20 mg/g PREDNISOLONE
MACROLONE
GRANULES
Anti-Inflammatory, anti-allergy
DIRECTIONS FOR USE:
PRECAUTIONS AND
CONTRAINDICATIONS:
DO
NOT
administer to
foals,
stallions or pregnant mares;
or to animals
suffering
laminitis, renal disease
or
corneal ulcers.
The
anti-inflammatory action may delay the healing
of
wounds and the repair
of
fractures,
particularly in
old animals.
In racing animals this product must
be withdrawn
prior to racing in accordance with the rules
of
racing.
DOSAGE AND ADMINISTRATION:
Administer
orally on alternate days at the rate
of
200 mg
Prednisolone/Sue kg bodyweight
(J
mg/2.5 kg) or
109
granules/500 kg bodyweight.
200
mg
Prednisolone is contained in
two
slightly
rounded measures
of
the measure provided.
WITHHOLDING PERIOD:
DO NOT
USE
less
than 28 days before slaughter for human
consumption.
STORAGE:
Store below 30°C (Room
Temperature).
Replace lid tightly after use.
DISPOSAL:
Dispose
of
container by wrapping in
paper and putting in garbage
NRA
Approval Number:
37438/0:'
\
~
,
Expiry
Date
Batch Number
150g
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NET CONTENTS
N.R.A"
I
APPROV~.
~
LABEL
(lEXT)
_.._
l
Label
No:
~!.~.:?~
j.9t
01
i
Date:
?
3.
..
.1
~)(.'.
'(Q~~'
d
Signature:
.'
.:
_AtfR_
/~
..
~
··
..
f
-
01
/.
,
.
'~~l'
• ..-
. ... .
~"-
. ..
~
,
I
Прочитайте повний документ
Характеристики продукта
MAVLAB PTY LTD
Date of Issue:
October 2007
MATERIAL SAFETY DATA SHEET
MACROLONE GRANULES
Page 1 of 5
MSDS version:
3
Date of Revision:
October, 2007
Update of section:
All sections
SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product (material) name:
Macrolone Granules Anti-Inflammatory Anti-Allergy
Other names:
Manufacturer's Code: P6600
Recommended use:
Prednisolone granules are recommended for the treatment of
inflammatory and
allergic conditions in dogs, cats and horses.
Supplier Details:
Mavlab Pty Ltd ACN 068 507 148
33 Rowland Street
SLACKS CREEK QLD 4127
Contact Person:
Dr Paul Ross
Emergency Telephone:
(07) 3808 1399
Facsimile:
(07) 3808 4328
SECTION 2 HAZARDS IDENTIFICATION
This product is not dangerous goods under the Australian Dangerous
Goods Code and is classified as not hazardous
according to the classification criteria of NOHSC:1008(2004), Approved
Criteria For Classifying Hazardous
Substances and the National Code of Practice for the Preparation of
Material Safety Data Sheets 2
nd
Edition
[NOHSC:2011(2003)]:
Poisons Schedule: S4
Although this product contains Prednisolone which would be classified
as hazardous according to the above criteria,
the concentration of Prednisolone present in this material is below
the concentration cut-off for classification of the
product as hazardous.
Health Effects
Swallowed:
May be harmful if swallowed
Eye:
Not expected to irritate the eyes.
Skin:
A single prolonged exposure is not likely to result in the material
being absorbed through the skin
in harmful amounts, however skin absorption may occur with prolonged
exposure.
Inhaled:
Inhalation exposure under normal conditions of use is not likely to
cause adverse effects, however
it may occur with prolonged exposure.
SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS
INGREDIENTS
Cas No.
Proportion
Prednisolone
[57-24-8]
< 14.0%
Sucrose
[57-50-1]
<90.0%
Starch-Maize
[9005-25-8]
< 60.0%
Cellulose-Powdered
[9004-34-6]
< 15.0%
Lactose-hydrous
[63-42-3]
< 30.0%
Sodium Lauryl Sulphate
[151-21-3]
< 5.0%
Sodium Sili
Прочитайте повний документ
